Message from the Medical Director

Throughout my 30-year career in Assisted Reproductive Technology (ART), I have faced immense challenges. Yet, from the very beginning, I held a firm belief that these technologies would never stop evolving—and time has proven me right. Today, infertility treatments offer higher success rates than ever before through a diverse range of advanced methods.

We have witnessed remarkable progress:

• Ovarian Stimulation: Once a painful and lengthy process for patients, it has evolved into user-friendly protocols where patients can self-administer medication with minimal to no discomfort.
• From Traditional IVF to ICSI: The development of ICSI (Intracytoplasmic Sperm Injection) has significantly increased fertilization success rates.
• Embryo Transfer Timing: Moving from Day 2 or Day 3 transfers to Blastocyst Stage (Day 5) transfers has yielded far superior clinical outcomes.
• Selective Transfer: We have shifted from transferring 3–4 embryos at a time to a Single Embryo Transfer (SET), effectively reducing the health risks associated with multiple pregnancies.
• Genetic Precision: We have progressed from transferring unscreened embryos to transferring a single embryo that has undergone Preimplantation Genetic Testing for Aneuploidies (PGT-A).

These experiences and milestones reinforce my belief that treating infertility is not just about technology; it is about providing close, compassionate care. By combining medical expertise with a deep understanding of every detail, we strive to help every couple experience the true joy of parenthood.